Toni Choueiri, MD
@drchoueiri.bsky.social
830 followers 64 following 36 posts
Director, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Kohberg Professor of Medicine, Harvard Medical School
Posts Media Videos Starter Packs
Reposted by Toni Choueiri, MD
danafarber.bsky.social
In 2023, the @fda.gov approved belzutifan for certain kidney cancers –– thanks to years of work led by Nobel Prize recipient William G. Kaelin Jr., MD. Now, @drchoueiri.bsky.social, director of our Lank Center for Genitourinary Oncology, and team are working to expand its clinical use.
Chain Reaction: The Belzutifan Journey | Dana-Farber Cancer Institute
Basic science discoveries made by Dana-Farber's William G. Kaelin Jr., MD, and his colleagues are propelling powerful new therapies for kidney cancer.
bit.ly
Reposted by Toni Choueiri, MD
danafarber.bsky.social
@drchoueiri.bsky.social‬ discusses promising results from the phase 1 ARC-20 study, exploring the combination of Casdatifan and cabozantinib in patients with previously treated clear cell renal cell carcinoma. #ASCO25
drchoueiri.bsky.social
“I can imagine no heroism greater than motherhood." - Happy Mothers day mom and all the mothers in the world ! #HappyMothersDay2025
Reposted by Toni Choueiri, MD
danafarbernews.bsky.social
We’re getting ready to wrap up #AACR25 today, but not before once again congratulating @danafarbernews.bsky.social’s Matthew Meyerson, MD, PhD, FAACR, @drchoueiri.bsky.social and Alice T. Shaw, MD, PhD, for receiving @theaacr.bsky.social 2025 Scientific Achievement Awards. bit.ly/4j7m8om
#AACR25 2025 Scientific Achievement Awards
drchoueiri.bsky.social
Thank you @theaacr.bsky.social for the Waun Ki Hong Award!

My talk will be addressing Precision Medicine in Renal Cell Carcinoma. See you in Chicago!

cc: @danafarber.bsky.social
drchoueiri.bsky.social
Thank you @theaacr.bsky.social for this honor !
danafarbernews.bsky.social
Congratulations to @danafarbernews.bsky.social’s Matthew Meyerson, MD, PhD, FAACR, @drchoueiri.bsky.social, and Alice T. Shaw, MD, PhD, recipients of @theaacr.bsky.social 2025 Scientific Achievement Awards. bit.ly/4j7m8om
Reposted by Toni Choueiri, MD
danafarber.bsky.social
“Our focused efforts are yielding results that are helping patients today and guiding our research towards more advances in the future,” says @drchoueiri.bsky.social. Learn about the research advancements our Lank Center for Genitourinary Oncology has made this past year.
A Year of Advances in Genitourinary Cancer
Published: February 6, 2025Written by: Beth DoughertyMedically Reviewed By: Atish Choudhury, MD, PhD, Toni Choueiri, MD, and Mark Pomerantz, MDDana-Farber’s genitourinary cancer team is devoted to res...
bit.ly
Reposted by Toni Choueiri, MD
gustaveroussy.fr
💬 Transatlantic Exchange : interview croisée du Dr @drchoueiri.bsky.social & du Pr Karim Fizazi.

Le 19 mars s’est tenue à Paris la 4e édition des Transatlantic Exchanges, une journée scientifique co-organisée par @gustaveroussy.fr et le @danafarber.bsky.social.

drchoueiri.bsky.social
“It may be that the satisfaction I need depends on my going away, so that when I've gone and come back, I'll find it at home”—Rumi, 13th century
drchoueiri.bsky.social
Another year, another #pickeball tournament with our good friend Rob Gronkowski #DaGronk to benefit our Research and Gronk Nation Youth Foundation. Join me and
donate at:

charity.pledgeit.org/pickleball/@to… #curecancere#beatgronknk
drchoueiri.bsky.social
This weekend, thanks to the support of the @redsox.com, @danafarber.bsky.social & @thejimmyfund.bsky.social gathered @fenwaypark.bsky.social to celebrate the impact of our Campaign. We celebrated our donors who help us defy Cancer together !
Reposted by Toni Choueiri, MD
danafarber.bsky.social
Yesterday, @drchoueiri.bsky.social and Karim Fizazi, MD, PhD, kicked off The Fourth Transatlantic Exchange in Oncology: Radiopharmaceutical Therapy Meets Oncology. Learn more about the collaborative event with @gustaveroussy.fr: bit.ly/42fC69Z
drchoueiri.bsky.social
Thank you @TownofWestwood and Lenny Strauss for highlighting our @PanMass journey the past several years, both @mvmombo and I. We are committed @DanaFarber to end Cancer!

hometownweekly.net/westwood/dr-ch…

Our @CowbellTeam Link for donations to cure Cancer: teammorecowbell.com/
https://hometownweekly.net/westwood/dr-ch…
drchoueiri.bsky.social
Happy International Women’s day to the wonderful GU Oncology Women’s @danafarber.bsky.social (front row)
Reposted by Toni Choueiri, MD
acir-org.bsky.social
Promising results: Adjuvant neoantigen vaccination prevents recurrence of kidney cancer bit.ly/3EUpSKG  @danafarber.bsky.social  @braunmdphd.bsky.social  @yalecancer.bsky.social  @drchoueiri.bsky.social
drchoueiri.bsky.social
#GU25 was an outstanding @ascocancer.bsky.social meeting: catching up with friends/ colleagues, watching mentees grow, learn up-to-date GU cancers management, and presenting a new HIF-2 inhibitor (casdatifan) data. Energized! The future is bright!

@danafarber.bsky.social @jrgralow.bsky.social
Reposted by Toni Choueiri, MD
crisbergerot.bsky.social
Updated results from the phase 2 LITESPARK-003 study on belzutifan + cabozantinib in advanced ccRCC patients! 📊💡 Key insights into combination therapy and improved outcomes @ascocancer.bsky.social #GU25 @drchoueiri.bsky.social
Reposted by Toni Choueiri, MD
crisbergerot.bsky.social
Great to have @drchoueiri.bsky.social stop by our poster @ascocancer.bsky.social #GU25! Appreciate the insightful discussion and your time.
Reposted by Toni Choueiri, MD
lizhighleyman.bsky.social
A customized kidney cancer vaccine made from patients’ tumors looked promising in a small study, @drchoueiri.bsky.social et al report in @nature.com. None of the 9 treated people experienced recurrence. Larger trial of mRNA vaccine underway.
www.cancerhealth.com/article/pers...
Personalized Vaccine May Help Prevent Kidney Cancer Recurrence
None of the nine patients who received the vaccine after surgery experienced recurrence over three years.
www.cancerhealth.com